Unaudited Financial Results for the Quarter Ended on 31.12.2025 along with Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd reported its Q3 FY26 (quarter ended December 31, 2025) unaudited standalone financial results. Total income for the quarter stood at Rs 24.89 lakhs, with a net loss of Rs 6.46 lakhs, narrower than the Rs 12.26 lakh loss in the same quarter last year. For the nine months ended December 2025, the net loss came in at Rs 18.85 lakhs, a notable improvement from Rs 34.16 lakhs in the corresponding nine-month period of FY25. The Limited Review Report by statutory auditors Jain Kedia & Sharma was clean, with no qualifications, modifications, or emphasis of matter. Separately, the Board approved the appointment of Mr. Vrushank Balkrushna Patel as the new Chairman & Managing Director for a five-year term, replacing Mr. Sarang Pathak who resigned.
The company remains loss-making but is showing clear improvement, with losses roughly halving year-on-year both for the quarter and the nine-month period, which is a positive sign for shareholders. The clean auditor report and a new leadership appointment may bring strategic direction changes, though continued losses mean the stock remains a higher-risk bet.